Hamburg/Sharfstein Agenda For FDA Emphasizes Collaboration
Executive Summary
Collaboration will be a key tool used by FDA Commissioner Margaret Hamburg as she leads the agency beyond its role as regulator to be a vigilant protector of public health
You may also be interested in...
Pediatric Safety For Anesthetic Drugs Boosted In FDA/IARS Initiative
FDA and the International Anesthetic Research Society have solidified their partnership for collaborating on the safe use of anesthetics and sedatives in children with a memorandum of understanding that focuses as much on communication as on research
Pediatric Safety For Anesthetic Drugs Boosted In FDA/IARS Initiative
FDA and the International Anesthetic Research Society have solidified their partnership for collaborating on the safe use of anesthetics and sedatives in children with a memorandum of understanding that focuses as much on communication as on research
FDA Appropriations In Senate: Money For Generics; Worry About Tobacco
Senate appropriators would like to see FDA spend $93 million in fiscal year 2010 on its generic drugs program